As the COVID-19 pandemic continues to affect the world and with the global rush in the development and distribution of vaccines, criminal groups and unscrupulous enterprising people have also been active in counterfeiting COVID-19-related health products. The Philippines through the Philippine Center on Transnational Crime, INTERPOL National Central Bureau, Office of the President of The Philippines has received reports that South African authorities have seized hundreds of fake COVID-19 vaccines and Some 400 ampoules containing the fake vaccine were found at a warehouse in Germiston, Gauteng. Further investigation by the INTERPOL revealed the presence of organized crime networks targeting COVID-19 vaccines, both physically and online. Concerned pharmaceutical companies assisted in the identification of fake vials. Criminals have been put behind bars and investigations are continuing.
According to a FDA Advisory No. 20210664 by The Philippines authorities on Public Health Warning on Fake COVID-19 Vaccines, it noted that in February 2021, the World Health Organization (WHO) reported that a falsified COVID-19 vaccine in Mexico identified as “BNT162b2”, manufactured by Pfizer- BioNTech with lot number 783201. The falsified product was supplied and administered to patients outside authorized vaccination programs. The genuine manufacturer of COVID-19 Vaccine BNT162b2 confirmed they did not manufacture the product. Laboratory analysis of the contents of the falsified products is still pending as of today. Falsified COVID-19 vaccines pose a serious risk to global public health and place an additional burden on vulnerable populations and health systems.
This story is from the BioSpectrum Asia May 2021 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the BioSpectrum Asia May 2021 edition of BioSpectrum Asia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Ushering Fourth Industrial Revolution in Telangana
Taking advantage of the 21st edition of BioAsia 2024 at the Hyderabad International Convention Centre (HICC) in Madhapur, the Government of Telangana, a southern state in India, leveraged the confluence of the global platform to spearhead initiatives aimed at propelling the state into the forefront of the Fourth Industrial Revolution (C4IR).
How Indian Biotech Investments are on a Doubling Spree
A latest report by Ankur Capital provides a closer look at the investments made in biotechnology in the last decade in the country.
"AI will be integrally involved in not only the diagnosis of cancer but also in determining the prognosis and best therapeutic option”
South Korea-based Deep Bio, a pioneering artificial intelligence (AI) healthcare firm focused on cancer pathology, is making waves in the industry.
"Because of its specificity and selectivity, ADCS have the potential to reduce adverse side effects and improve patient survival"
Japan-headquartered Daiichi Sankyo, the global healthcare company, launched its subsidiary Daiichi Sankyo Singapore Pte. Ltd. to bridge unmet needs in oncology.
Can Test, Treat, Track Beat Malaria?
Malaria has long been a major public health concern in the Asia Pacific region, particularly in South East Asia (SEA) affecting millions of people.
Engineering CAR T cell sharpshooters
Approved CAR T-cell therapies have shown remarkable results in patients with certain types of blood cancers.
Addressing Challenges in Cell Therapy Manufacturing
Even with significant advancements, there are still anumber of issues with cell therapy manufacturing that need to be resolved as production grows.
"We anticipate India will adopt decentralised models for managing CGTs, ensuring closer proximity between patients and treatment facilities"
Cell and gene therapy (CGT) expert from Germany, Miltenyi Biotec has recently announced its entry into the Indian market to provide researchers, scientists and clinicians easier access to expertise, research, and manufacturing solutions.
Addressing Accessibility and Affordability of CELL & GENE THERAPIES
Cell and gene therapies (CGT) are one of the hottest sectors in the pharmaceutical industry.
Korea designs sweat resistant wearable robot sensor
New electromyography (EMG) sensor technology that allows the long-term stable control of wearable robots and is not affected by the wearer's sweat and dead skin has gained attention recently.